Literature DB >> 33953633

Aseptic Meningitis after Recovery from SARS-CoV-2 in an Allogeneic Stem Cell Transplant Recipient.

Fahmin Basher1, Jose F Camargo2, Meilin Diaz-Paez3, Lazaros J Lekakis3, Denise L Pereira3.   

Abstract

SARS-CoV-2 emerged as a worldwide pandemic in late 2019 and initially was described as a primary respiratory illness. The clinical manifestations of COVID-19 are now known to encompass nearly all organ systems, including the central nervous system. We present a case of an allogeneic hematopoietic stem cell transplant recipient who recovered from documented SARS-CoV-2 infection and later presented with symptoms of meningitis. While cerebrospinal fluid analysis did not reveal any bacterial or viral etiologies, evidence of an inflammatory state, including ophthalmologic findings of episcleritis, indicate what is likely the first reported case of aseptic meningitis associated with SARS-CoV-2 infection after initial clinical recovery.
© The Author(s) 2021.

Entities:  

Keywords:  COVID-19; Meningitis; SARS-CoV-2; allogenic stem cell transplant; coronavirus

Year:  2021        PMID: 33953633      PMCID: PMC8058782          DOI: 10.1177/11795476211009811

Source DB:  PubMed          Journal:  Clin Med Insights Case Rep        ISSN: 1179-5476


  61 in total

1.  Herpes simplex virus encephalitis after allogeneic transplantation: an instructive case.

Authors:  R Romee; C G Brunstein; D J Weisdorf; N S Majhail
Journal:  Bone Marrow Transplant       Date:  2009-08-24       Impact factor: 5.483

Review 2.  The challenge of drug-induced aseptic meningitis revisited.

Authors:  German Morís; Juan Carlos Garcia-Monco
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

3.  Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents.

Authors:  Martin Schmidt-Hieber; Julie Schwender; Werner J Heinz; Tatjana Zabelina; Jörn S Kühl; Sabine Mousset; Silke Schüttrumpf; Christian Junghanss; Gerda Silling; Nadezda Basara; Stefan Neuburger; Eckhard Thiel; Igor W Blau
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

4.  Severe acute respiratory syndrome coronavirus and viral mimicry.

Authors:  Fook Tim Chew; Su Yin Ong; Choy Leong Hew
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

5.  Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation.

Authors:  Aimee E Hammerstrom; Joshua Howell; Alison Gulbis; Gabriela Rondon; Richard E Champlin; Uday Popat
Journal:  Am J Hematol       Date:  2013-03-05       Impact factor: 10.047

6.  Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.

Authors:  Darja Kanduc; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2020-09-18       Impact factor: 2.829

7.  Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.

Authors:  Abdul Mannan Baig; Areeba Khaleeq; Usman Ali; Hira Syeda
Journal:  ACS Chem Neurosci       Date:  2020-03-13       Impact factor: 4.418

8.  COVID-19 outcomes in patients with hematologic disease.

Authors:  Florent Malard; Alexis Genthon; Eolia Brissot; Zoe van de Wyngaert; Zora Marjanovic; Souhila Ikhlef; Anne Banet; Simona Lapusan; Simona Sestilli; Elise Corre; Annalisa Paviglianiti; Rosa Adaeva; Fella M 'Hammedi-Bouzina; Myriam Labopin; Ollivier Legrand; Rémy Dulery; Mohamad Mohty
Journal:  Bone Marrow Transplant       Date:  2020-05-06       Impact factor: 5.483

9.  COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features.

Authors:  Neo Poyiadji; Gassan Shahin; Daniel Noujaim; Michael Stone; Suresh Patel; Brent Griffith
Journal:  Radiology       Date:  2020-03-31       Impact factor: 11.105

Review 10.  Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.

Authors:  Jia-Mei Liu; Bai-Hong Tan; Shuang Wu; Yue Gui; Jia-Le Suo; Yan-Chao Li
Journal:  J Med Virol       Date:  2020-10-14       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.